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Abstract 
Background: In Canada, incidents of new hepatitis C virus infections are rising among women aged 
15–29 years and now comprise 60% of new infections among this age group. A negative diagnosis 
experience continues to be a problem affecting women living with hepatitis C virus. With new effective 
treatments, nurses will have more involvement in hepatitis C virus care and diagnosis, which is a 
critical time to facilitate appropriate education and management. Purpose: This study explored 
Canadian women’s experience of hepatitis C virus diagnosis in order to develop recommendations to 
improve care at the point of diagnosis. Methods: Purposive sampling was used to recruit and interview 
25 women. Using narrative inquiry, we examined Canadian women’s experience of hepatitis C virus 
diagnosis. Results: Women’s diagnosis experiences were shaped by the context of diagnosis, factors 
prompting the testing, the testing provider, and information/education received. The context of 
diagnosis foreshadowed how prepared women were for their results, and the absence of accurate 
information magnified the psychological distress that can follow an hepatitis C virus diagnosis. 
Conclusion: Our findings provide a compelling case for a proactive nursing response, which will 
improve women’s experiences of hepatitis C virus diagnosis and, in turn, enhance women’s access to 
hepatitis C virus care and other healthcare services. 
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Introduction 
Hepatitis C virus (HCV) is a chronic blood-borne infection that affects an estimated 250,000 Canadians 
(Borman & Swain, 2013). The majority of new HCV cases are among people who inject drugs (Public 
Health Agency of Canada, 2009). Although men carry a disproportionate burden of illness with 65% of 
all new Canadian HCV cases in 2013 (Communicable Disease Prevention and Control Services, 2013) 
the gender gap is narrowing. Incidents of new HCV infections are rising among women aged 15–29 
years and have exceeded the rates of men in this age category (Communicable Disease Prevention and 
Control Services, 2013). Generally, the social impact and access to care can be more burdensome for 
women with chronic illness, especially those with pronounced associated stigma such as with HCV 
(Butt, 2008). 
Early diagnosis of HCV in women is critical to facilitate timely, appropriate care and management, 
which have been shown to improve quality of life and liver function, decrease risk of liver cancer, and 
improve survival (Hung et al., 2006; Yoshida et al., 2002). Due to the large numbers affected and the 
relative shortage of specialists in Canada, HCV diagnosis and follow-up tends to be provided at first 
point of contact with healthcare services (Zevin, 2007). However, there are no national HCV testing 
guidelines for HCV diagnosis, including pre-and post-test discussion, to guide standards for diagnosis 
care.  
There is evidence that the point of diagnosis is a critical time for accessing and engaging in HCV care 
and support (Treloar, Harris, Deacon, & Maher, 2010). Diagnosis has been described as an 
overwhelmingly poor experience and has also been described as being trivialized by healthcare 
providers (Davis, Rhodes, & Martin, 2004). Previous research has noted that people living with HCV 
have perceived clinicians as having “negative attitudes” toward them and reported being provided with 
neither information nor support (Crockett & Gifford, 2004; Treloar et al., 2010).  
For people living with HCV, their level of knowledge about the disease can influence health outcomes 
(Glacken, Kernohan, & Coates, 2001). Lack of information and support during HCV diagnosis can 
potentially further reduce follow-up and HCV management (Treloar et al., 2010), as fear of the disease 
increases and feelings of loss of control over one’s health are generated (Hopwood & Treloar, 2004). 
HCV is a highly stigmatized disease that is closely associated with drug use (Butt, Patterson, & 
McGuiness, 2008) and women may be more adversely affected by such stigma given typical gender 
roles and social expectations. Therefore, a qualitative analysis of women’s accounts of diagnosis can 
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provide insights into current practice, which can inform and direct nursing clinical practice and 
programs to ensure women are receiving the information and support they require at this critical point 
in their life.  
Although our research on the experience of diagnosis was undertaken prior to the present major 
advances of interferon-free HCV treatment, which have given new hope of speedy and less 
burdensome treatment, these new treatments alone will not solve the burden of HCV. The role of 
nurses in HCV care is expanding from specialty clinics into general practice, thus highlighting the need 
for these issues of diagnosis and clinical pathways into care to be refined. In this paper, we examine 
Canadian women’s experiences of HCV diagnosis to develop recommendations to improve care at the 
time of diagnosis that will, in turn, enhance women’s access to these new treatments and other services.  
 
Methods 
The qualitative research design of narrative inquiry methodology was used in this study to allow for 
inquiry into women’s experiences. This approach enabled an exploration of the women’s life 
experiences using “story” to describe and analyze the experiences of living with HCV from the 
perspective of the women. Narratives were used to understand and make sense of various life events 
described by the women who lived them (Chase, 2011; Creswell, 2009). How the women chose to 
narrate their experiences or tell their story and what they included helped to construct meaningful 
identities and realities of their experience (Chase, 2011).  
Recruitment: Twenty-five women with self-reported HCV were recruited through community clinics 
and support agencies, specialist clinics, public health, prison health, and outreach services. Purposeful 
sampling using snowball and word-of-mouth sampling strategies were used to ensure participants were 
recruited that could provide insight into the research question. Information pamphlets and flyers were 
provided to these sites for distribution to potential participants. Healthcare providers at these sites also 
targeted eligible women and asked if they would be willing to participate in a telephone interview 
about their experience of living with HCV.  
To maximize confidentiality and accessibility participants were interviewed by phone on a toll-free 
line. When participants expressed an interest they were referred to the toll-free telephone number to 
contact a member of the research team.  To facilitate participation for women without phones, 
community agencies provided a private space and telephone. During the initial call, participants were 
informed about the aims of the research and asked preliminary questions to ensure they met the 
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selection criteria: self-reported HCV infection, aged 19 years or older, English language fluency, and 
no conditions that significantly impeded cognition, memory, or the ability to give consent (e.g., 
dementia, psychosis etc.).  
Verbal consent was obtained during the initial contact with participants. Written consent was then 
obtained from all participants either via post or e-mail prior to the full interview. Telephone numbers 
were exchanged with eligible participants and a suitable call back time to conduct the interview was 
arranged; occasionally the interview occurred immediately. 
Data Collection: An interview guide, based on input from an expert advisory committee comprised of 
healthcare providers and women living with HCV, was used to facilitate exploration and enrich the data 
(Smith, 1995). Women were interviewed by one of three trained interviewers who collected 
standardized demographic and open-ended exploratory questions that assisted with probing the issues 
and facilitated further exploration of perceptions, experiences and areas of interest contributing to the 
women’s experiences of living with HCV and health-service utilization. Interviews lasted 45-90 
minutes and were audio-recorded and transcribed.  
Data Analysis: NVivo 9TM software was used as a tool to assist with organizing the qualitative data. 
This management system allowed the researchers to interrogate the data in an effective and efficient 
way. Transcripts were read and an initial coding structure was developed using open coding to identify 
concepts and categories in the data, which formed the components for the analysis. Once an initial 
coding structure was established the research team simultaneously coded five randomly selected 
transcripts and compared coding similarities and differences among the team members. As new codes 
and issues were identified as being significant along the journey to care such as point of diagnosis, the 
narratives were reread and recoded with focused coding using the initial codes to synthesize and 
scrutinize the data. The coding structure was refined to produce an inclusive list of codes through 
consensus that represented the range of women’s experiences included in the narratives. Constant 
comparison was used to examine similarities and differences and ensure that the data continued to 
support the emerging categories.  
Memos were kept to record thoughts, interpretations, and questions about the data and their 
interpretation. The stories and events were the data and narrative inquiry was used to construct 
descriptive narratives that connected the stories in a meaningful way. This approach allowed for a 
deeper understanding and empathy for the life experience of the women living with HCV (Schwandt, 
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2007). Recruitment ceased shortly after data saturation was reached as no new codes or themes were 
identified.  
Ethical Considerations: Ethics approval was granted by the University of British Columbia, the 
University of Sydney and the Public Health Agency of Canada’s Human Research Ethics Committees. 
Prior to interviews, written and oral information was provided and reviewed with all participants and 
signed consent forms were collected. Data confidentiality was maintained by using codes in place of 
personal identifiers and restricting transcript and data access to the research team. Participants received 
a $40 honorarium for their time and incidental costs. Pseudonyms were used throughout data collection 
and analysis to ensure participant confidentiality.  
 
Results 
The sample comprised 25 women with self-reported HCV from three Canadian provinces. Two of 
these provinces together account for 60% of all reported cases in Canada (Public Health Agency of 
Canada, 2011). The sample was geographically diverse with women from urban, suburban, and rural 
areas. Women were at various stages of the lifespan and HCV illness. The majority (24/25) were aged 
30 years or older. Twelve participants received their diagnosis more than 10 years ago and seven within 
the past five years. More than half the women had received HCV antiviral treatment. The majority of 
the women were diagnosed by their general practitioner (GP), methadone maintenance therapy 
prescriber or by a doctor at a walk-in primary health clinic. 
Through our analysis, we found two interrelated themes in understanding the women’s experiences of 
diagnosis: (1) how prepared the women were for their positive diagnosis, and (2) information and 
health education received at point of diagnosis.   
Preparedness: The women’s narratives illustrated that varied circumstances contributed to receiving a 
HCV diagnosis and, ultimately, their level of preparedness. The first of these circumstances was 
reported by eight women who described HCV testing in the context of seeking healthcare for “feeling 
unwell” or “knowing something was wrong.” Symptoms often included jaundice and severe abdominal 
pain, which they did not necessarily attribute to HCV. Their health-provider initiated testing for HCV 
and the women were often unaware they were being tested. Consequently, when diagnosed, women 
were often ill-prepared, as they had not considered the possibility of HCV infection. They reported 
being puzzled and questioned their exposure source, which was often many years prior to the diagnosis.  
Canadian women's diagnosis experiences 
 
6 
In the second circumstance 11 women described being tested during a routine examination for a health 
insurance application, in follow-up blood tests for abnormal liver enzymes, or screening after blood 
donations. As the screen was done as a matter of routine and at a range of locations, no risk assessment 
was completed. Again, some women were unaware they were being tested for HCV. Women were not 
expecting positive results and they reported feeling unprepared, shocked (as they felt well), and 
bewildered when told of their HCV diagnosis. The absence of a risk assessment prior to diagnosis 
created enormous confusion for the women as they had little knowledge about HCV and its 
transmission routes. The example below highlights both an unacceptable breach of confidentiality in 
small community hospital and how a lack of information and counseling results in further unnecessary 
confusion. 
My insurance agent called me between that Christmas and New Years to tell me that I was 
turned down, and I said, “oh why, was my blood pressure too high?” My sister-in-law had just 
gone to the hospital that day and she said, “no, don’t you know that you have hep C?”... 
Needless to say, I did not take it seriously. “You’re joking”, you know, because I was still under 
the idea that it was mostly drug addicts [Kathy, diagnosed 2002]. 
The final set of circumstances involved women who sought HCV testing. The context for some women 
was the presence of known risk factors, which prompted women or their health-provider to seek HCV 
testing at a drug treatment program or primary health clinic. Risk factors included past or current drug 
use, blood transfusion, and mother-child transmission. Generally, these women were aware of an 
exposure event or that their practices put them at risk. Thus, the women were prepared for a positive 
diagnosis and, after the initial shock, accepted it and were able to explain it in terms of their drug use.  
For example:  
I was doing a complete turnaround at the that time and I said okay, I’m getting out of addiction, 
I’m changing my lifestyle but I wanna make sure, did I get out scott free? [Kerri, diagnosed 
2005]. 
But in other situations when women sought testing because of risk-exposures, they were unprepared for 
the positive diagnosis. For example, between 1986 and 1990 a number of Canadians were infected with 
HCV via blood products during hospital procedures (Norris, 2008). Following media reports of tainted 
blood, two participants made the decision to get tested. Another participant was tested because both 
parents were HCV positive. In these three cases, the decision to be tested was the result of a risk 
exposure. However, the women’s response to a positive result was similar to those who had routine 
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testing: unprepared for and surprised by the diagnosis as they were unaware of their exposure source 
and uninformed about HCV prognosis. Tanya described getting diagnosed at an early age when the 
child protection agency became involved. When she received her results she had no knowledge of 
HCV. 
The Ministry had got involved and, uh, I had to do blood work, I can’t remember what, I was 
really young, but um, yeah, the blood work came back and said I was positive and I hadn’t had 
any sexual partners or anything like that or done any drugs so that kind of leaves only one 
reason, you know? One reason. And both my parents were hep C positive… So, yeah, that’s 
when I got that diagnosis, I didn’t really know what it means [Tanya, diagnosed 2000]. 
Information and Health Education Received at Point of Diagnosis: An HCV diagnosis can create 
distress and confusion for women when considering how this diagnosis will impact their health in the 
future. This distress and confusion can be exacerbated if women receive limited information or 
misinformation about prognosis from their healthcare provider. The women in this study described 
varying experiences of information provision ranging from none, to limited or inadequate, to 
appropriate and adequate information for health management.  
Irrespective of time since diagnosis (that is, from more than 10 years before interview to within the past 
five years), women described receiving limited information at diagnosis. The women who described 
not receiving HCV-related information, being uninformed about the need for follow-up, or not being 
told how to manage their HCV at the point of diagnosis described the experience as confusing and 
distressing; they were left wondering about the consequences of HCV. For some of the women in our 
study, a negative experience and inadequate information at diagnosis resulted in further disengagement 
from care.  
For many women, their HCV diagnosis raised significant concerns about current and future health-
status. Some described believing they were going to die soon after diagnosis and so they had no reason 
to inquire further about HCV or make changes in their lives. Others had no sense of the seriousness of 
HCV. One participant was given no information: 
When I was diagnosed with hepatitis C I was barely a woman right and told that I’m goanna 
die.  That’s exactly what they said like you’re, don’t expect to live very long because twenty 
years from now you’re going to be really sick and then you’re goanna die [Jackie, diagnosed 
2000].  
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As a result Jackie was unaware of the need for on-going liver monitoring and she received no follow-
up.  It was not until years later when, following abnormal blood-work results during a routine physical 
exam, further investigations were performed and appropriate medical-care was provided.  
Regardless of the circumstance that prompted the HCV test, information provided by healthcare 
providers at the time of diagnosis shaped women’s subsequent health and healthcare experiences. 
Living for years with incorrect information about prognosis left Jackie feeling she could have done 
things differently and made changes sooner “if only I’d been told” earlier about the consequences and 
need for follow-up. Some women attributed the lack of information to inadequate knowledge of their 
healthcare provider, others to the lack of information existing at the time. For example:  
Well, in the beginning when I got the diagnosis the doctor that I saw basically gave me a 
pamphlet and said, “you know we don’t really know much about this but maybe you know you 
might have two years to live,” kind of thing”... The doctor said that as long as I didn’t have any 
symptoms that I would be ok.  [Kerri, diagnosed 1992] 
 A more recent diagnosis did not appear to improve information provision. Some participants 
diagnosed within the last decade reported being informed by their healthcare provider that the 
information they had received at diagnosis (by another healthcare provider) was incorrect. One 
participant, diagnosed in 2007 by her GP, was provided with no information on follow-up or 
management of HCV.  
I said, “I have no energy and I’m sleeping so much”, so I asked him if he could take, check my 
blood out and then he told me that I had hep C. He told me, he said, “maybe that’s why you’re 
getting so tired” and that’s it, I couldn’t believe it, he didn’t really say anything about it… He 
didn’t say anything about what you should do [Becky, diagnosed 2007]. 
A small number of the women diagnosed in the last decade reported receiving what they characterized 
as sufficient information about HCV. These women said they felt prepared to make informed decisions 
about their healthcare management. Most of these women were diagnosed by a healthcare provider 
with whom they had an established relationship. They described feeling empowered and motivated to 
make lifestyle changes:  
[When I was diagnosed]…they, were supportive of me and they, you know, they told me in 
terms I could understand, like to begin to educate me a bit about it. Um, and um, yeah, I was 
able to kind of figure it out a bit… ah; it kind of, it actually gave me, incentive to get my life 
Canadian women's diagnosis experiences 
 
9 
together. It took a few years but it’s been some, it’s, I had something to work towards to, you 
know, kind of like take control of my health [Lisa, diagnosed 2005]. 
 
Discussion 
The past two-and-half decades have seen much progress in the understanding of management and 
treatment of HCV. Nevertheless, negative experience and inadequate information at diagnosis 
continues to be a problem affecting women living with HCV, resulting in further disengagement from 
care and long-term consequences to their understanding of HCV and its management (Hopwood & 
Treloar, 2004; Treloar et al., 2010). Women in our sample described not knowing what to do post-
diagnosis, or being told there was nothing they could do. This finding contrasts strongly with the sense 
of empowerment described by the few women who felt they received good information. 
A HCV diagnosis can cause major psychological distress, which may be more troubling when little or 
no reliable information about prognosis is provided (Castera, Constant, Bernard, de Ledinghen, & 
Couzigou, 2006). The diagnosis experience for women can have significant implications on social 
functioning. The perceived stigma associated with HCV can produce anxiety and amplify fears of 
transmission, which may lead to social isolation and limited intimacy in relationships (Miller, McNally, 
Wallace, & Schlichthorst, 2012). Two important findings stemming from our analysis reinforce claims 
that the process of diagnosis has major implications for HCV care. These findings contribute to the 
knowledge base and should inform the continuing development of strategies aimed at improving the 
HCV diagnosis experience.  
Preparedness: Women are diagnosed with HCV in a range of settings and after a variety of prompts. 
In our study, the context of the diagnosis often foreshadowed how prepared they were for the results. 
Women who received limited information pre-diagnosis were less prepared and shocked by the results. 
On the other hand, the few women who were well-informed about HCV prior to diagnosis – generally 
those who had sought testing or where tested following risky practices – had a base from which to ask 
questions. For example, women who were diagnosed during routine blood-work or for insurance 
purposes were neither prepared for nor anticipating a positive result. Moreover, these women were 
more likely to be diagnosed in a setting where their healthcare provider was less informed about HCV. 
Being unprepared for a HCV diagnosis can trigger feelings of shock and devastation, which can lead to 
long-term emotional, psychosocial, and physical-effects and be a barrier to accessing care (Miller et al., 
2012). 
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Information and Health Education: Health education and effective communication of management 
plans can influence patients’ emotional and physiologic status and significantly impact health-
outcomes (Stewart, 1995). Communication interventions and patient health-outcomes are correlated; 
effective communication can positively influence the patient’s emotional health, symptom management 
and physiologic status, (Stewart, 1995). The women in our study were generally provided with 
inadequate or incorrect information at diagnosis leaving them confused and unsure about follow-up and 
management. This situation negatively impacts relationships with healthcare providers, which can 
create a barrier and avoidance of future healthcare (Miller et al., 2012). 
Our study raises concerns about how often women are being educated to make informed decisions 
about their HCV care. Discussing the meaning of a positive result can help women understand their 
diagnosis and take control of their subsequent health behaviors (Gifford, O’Brien, Bammer, Banwell, 
& Stoove, 2003). Our results highlight the importance for nurses to have suitable training to equip them 
with the knowledge and skills to provide appropriate information and holistic care for women living 
with HCV. The findings also emphasize the significance of inquiring about each woman’s prior 
knowledge of HCV and not assuming adequate information has been provided to her at diagnosis. Each 
interaction is an crucial opportunity for nurses to correct or update information that may lead to better 
care and increase women’s sense of control over their healthcare experiences and future health 
outcomes (Hibbard & Peters, 2003).  
HCV is a stigmatized condition due to the association with injection drug use. A negative experience at 
diagnosis can lead to disengagement and create a barrier to, and avoidance of, healthcare, which will 
damage future relationships with healthcare providers (Treloar et al., 2010) and potentially negatively 
impact treatment and interventions. This potential outcome is important for all people diagnosed with 
HCV, but it is especially pertinent to women who may undergo testing while pregnant. Pregnancy is a 
particularly vulnerable time for women because they often feel judged and their behaviour and lifestyle 
may be scrutinized, especially for those with a history illicit drug injection (Olsen, Temple-Smith, & 
Banwell, 2013). Therefore, given the role of nurses and midwives in the care of women at this time, a 
sound understanding of HCV is crucial for appropriate care. 
Implications for Practice and/or Policy: Understanding women’s experience at HCV diagnosis has 
implications for nursing practice, policy, and future research, especially as new highly effective 
treatments become more available, thus expanding the role of nurses in this area. Improving this 
experience can be the first step towards improving health-outcomes and reducing the burden of the 
disease for the growing number of women living with HCV. As found in our research, women are 
Canadian women's diagnosis experiences 
 
11 
diagnosed in a variety of settings, but HCV awareness, knowledge, and expertise are not evenly 
distributed across these diverse settings. Our findings provide a clear and compelling case for a national 
HCV testing guideline for HCV diagnosis, including pre-and post-test discussion, to guide standards 
for diagnosis care, which can address the inequalities women face when diagnosed with HCV. 
Although pre-and post-test guidelines for HCV have been identified as important for prevention and 
care (Watson & Kosky, 1999), they are currently lacking in a number of settings, including in Canada, 
which was the site of this research. Without consistent HCV pre-and post-test guidelines, nurses and 
other healthcare providers will continue to provide variable information during pre-test and post-test 
discussions, if any is delivered at all (Munoz-Plaza, Strauss, Astone, Des Jarlais, & Hagan, 2005).  
The HCV diagnosis process is described as being trivialized by healthcare providers (Davis et al., 
2004), yet the point of diagnosis is an important window of opportunity for education and engagement 
into care and treatment. Though it is concerning that so few women diagnosed within the last decade 
received what they judged to be adequate information about HCV from their healthcare provider in an 
era when treatment was theoretically available, it is perhaps unsurprising given the lack of diagnosis 
and management guidelines. Although guidelines cannot guarantee appropriate care at diagnosis, they 
can be effective in ensuring minimum standards of care are met.  
Effective HCV diagnosis depends on policies, strategies, frameworks, and standards that focus on 
education for nurses and all healthcare providers around the point of diagnosis. Implementation of pre-
and post-test guidelines would facilitate referral into care and treatment at the point of diagnosis and 
possibly reduce barriers to care, which otherwise could lead to unnecessary disease progression and, 
ultimately, reduce the overall burden of the disease in Canada (Krajden et al., 2010; Yu, Spinelli, Cook, 
Buxton, & Krajden, 2013) 
As the new highly effective HCV treatments, with greater tolerability and much lower toxicity become 
accessible across Canada, HCV care and treatment is likely to move away from the specialist clinic and 
out to the broader public healthcare sector. It is therefore essential that adequate and appropriate 
information about prognosis, treatment options and the ongoing need for healthcare is provided at the 
point of diagnosis to ensure those affected have the necessary knowledge and access to care. Our 
research has demonstrated the impact the diagnosis experience has on Canadian women living with 
HCV and highlights the need for a proactive response from healthcare providers which will improve 
women’s experiences of HCV diagnosis and, in turn, enhance women’s access to HCV care and other 
healthcare services. 
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